Efficacy and Safety of DA-9401 on Improvement of Sperm Motility

Spermatocele Clinical Trial

Official title:
A 12-week, Multi-center, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Allium Cepa L. and Cuscuta Chinensis Lam. Extract Mixtures (DA-9401) on Improvement of Sperm Motility

Status Completed

Clinical Trial Summary

This study was conducted to investigate the effects of daily supplementation of Allium cepa L. and Cuscuta chinensis Lam. Extract Mixtures (DA-9401) on improvement of sperm motility.

Clinical Trial Description

This study was a 12 weeks, multi-center, randomized, double-blind, placebo-controlled human trial. Twenty subjects were randomly divided into Allium cepa L. and Cuscuta chinensis Lam. Extract Mixtures (DA-9401) or a placebo group. sperm motility profiles before and after the intervention. ;

Study Design

Related Conditions & MeSH terms

Spermatocele

Clinical Trial Details

NCT number	NCT03258437
Study type	Interventional
Source	Korean Society for Sexual Medicine and Andrology
Contact
Status	Completed
Phase	N/A
Start date	April 12, 2016
Completion date	January 30, 2018

View Details

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT05617261` - Evaluating Patient Tolerability and Success for Penile and Scrotal Urologic Procedures Under Conscious Sedation: A Prospective Study
	Recruiting	`NCT06242977` - Efficacy of EMLA Cream Assisted Loco-sedation for Office-based Andrology Procedures	Phase 3